Clinical Evaluation of the Scopio Cell Morphology Technology

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Aug 26, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new technology called Scopio Cell Morphology, which uses artificial intelligence (AI) to help analyze blood samples from patients with blood cancers. The goal is to see how well this AI-based system compares to traditional methods of examining samples under a regular microscope. Researchers want to find out if the AI can provide accurate readings that help doctors make better decisions about treatment.

To participate in this trial, you would need to be between the ages of 65 and 74 or 29 and 219 and diagnosed with a blood disorder that allows your bone marrow samples to be examined under a microscope. Unfortunately, if you do not have a blood disorder or if your samples cannot be properly examined this way, you wouldn’t be eligible. If you join the trial, you can expect to contribute to important research that could lead to improved ways of diagnosing and treating blood cancers in the future. Please note that the trial is not yet recruiting participants, so keep an eye out for updates if you think you might be interested.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients suffering from hemopathies with bone marrow aspirate assessable under the optical microscope
• Exclusion Criteria:
• • Patients not affected by blood disorders
• • Patients suffering from hemopathies with bone marrow aspirate that cannot be assessed under the optical microscope